These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22035371)

  • 1. Nephrogenic systemic fibrosis: a case report and review on Japanese patients.
    Matsumoto Y; Mitsuhashi Y; Monma F; Kawaguchi M; Suzuki T; Miyabe C; Igarashi A; Tsuboi R
    J Dermatol; 2012 May; 39(5):449-53. PubMed ID: 22035371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nephrogenic systemic fibrosis: a systemic fibrosing disease resulting from gadolinium exposure.
    Bernstein EJ; Schmidt-Lauber C; Kay J
    Best Pract Res Clin Rheumatol; 2012 Aug; 26(4):489-503. PubMed ID: 23040363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nephrogenic systemic fibrosis: a concise review for cardiologists.
    Cheong BY; Muthupillai R
    Tex Heart Inst J; 2010; 37(5):508-15. PubMed ID: 20978560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is your diagnosis. Nephrogenic systemic fibrosis.
    Zaleski L; Xia Y; Cho S
    Cutis; 2011 Jan; 87(1):13, 19-20. PubMed ID: 21323094
    [No Abstract]   [Full Text] [Related]  

  • 5. Gadolinium-associated nephrogenic systemic fibrosis in a 9-year-old boy.
    Foss C; Smith JK; Ortiz L; Hanevold C; Davis L
    Pediatr Dermatol; 2009; 26(5):579-82. PubMed ID: 19840315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nephrogenic fibrosing dermatosis: From clinic to microscopy].
    Yoldez H; Ahlem B; Abderrahim E; Faten Z; Soumaya R
    Nephrol Ther; 2018 Feb; 14(1):47-49. PubMed ID: 29239786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nephrogenic Systemic Fibrosis Manifesting a Decade After Exposure to Gadolinium.
    Larson KN; Gagnon AL; Darling MD; Patterson JW; Cropley TG
    JAMA Dermatol; 2015 Oct; 151(10):1117-20. PubMed ID: 26017458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nephrogenic systemic fibrosis: fibrotic plaques and contracture following exposure to gadolinium-based contrast media.
    He A; Kwatra SG; Zampella JG; Loss MJ
    BMJ Case Rep; 2016 Apr; 2016():. PubMed ID: 27073153
    [No Abstract]   [Full Text] [Related]  

  • 9. Recent topics related to nephrogenic systemic fibrosis associated with gadolinium-based contrast agents.
    Kitajima K; Maeda T; Watanabe S; Ueno Y; Sugimura K
    Int J Urol; 2012 Sep; 19(9):806-11. PubMed ID: 22571387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A unique case of nephrogenic systemic fibrosis from gadolinium exposure in a patient with normal eGFR.
    Lohani S; Golenbiewski J; Swami A; Halalau A
    BMJ Case Rep; 2017 Oct; 2017():. PubMed ID: 29025775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nephrogenic systemic fibrosis: an emerging entity.
    Saxena SK; Sharma M; Patel M; Oreopoulos D
    Int Urol Nephrol; 2008; 40(3):715-24. PubMed ID: 18418727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Causal relationship between the use of gadolinium based contrast media and nephrogenic systemic fibrosis].
    Varela CU; Prieto-Rayo JC
    Rev Med Chil; 2014 Dec; 142(12):1565-74. PubMed ID: 25693439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nephrogenic systemic fibrosis: a severe complication of use to gadolinium in patients with kidney failure].
    Mundim JS; Lorena Sde C; Abensur H; Elias RM; Moysés RM; Castro MC; Romão Júnior JE
    Rev Assoc Med Bras (1992); 2009; 55(2):220-5. PubMed ID: 19488662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue gadolinium deposition and fibrosis mimicking nephrogenic systemic fibrosis (NSF)-subclinical nephrogenic systemic fibrosis?
    Boyd AS; Sanyal S; Abraham JL
    J Am Acad Dermatol; 2010 Feb; 62(2):337-42. PubMed ID: 19939504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contemporary applications and limitations of magnetic resonance imaging contrast materials.
    Natalin RA; Prince MR; Grossman ME; Silvers D; Landman J
    J Urol; 2010 Jan; 183(1):27-33. PubMed ID: 19913804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late Onset Nephrogenic Systemic Fibrosis in a Patient with Stage 3 Chronic Kidney Disease: a Case Report.
    Lim YJ; Bang J; Ko Y; Seo HM; Jung WY; Yi JH; Han SW; Yu MY
    J Korean Med Sci; 2020 Sep; 35(35):e293. PubMed ID: 32893521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Nephrogenic systemic fibrosis].
    Becker S; Witzke O; Kribben A
    Med Klin (Munich); 2009 Mar; 104(3):204-9. PubMed ID: 19337710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The debate between gadolinium versus erythropoietin in a renal transplant patient with nephrogenic systemic fibrosis.
    Hashemi P; Sina B; Rietkerk W; Safai B
    J Nephrol; 2013; 26(1):48-54. PubMed ID: 22573525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephrogenic systemic fibrosis: concepts and perspectives.
    Igreja AC; Mesquita Kde C; Cowper SE; Costa IM
    An Bras Dermatol; 2012; 87(4):597-607. PubMed ID: 22892775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephrogenic systemic fibrosis, in patients with end-stage kidney disease on dialysis, in the greater Auckland region, from 2000-2006.
    Kendrick-Jones JC; Voss DM; De Zoysa JR
    Nephrology (Carlton); 2011 Feb; 16(2):243-8. PubMed ID: 21272139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.